Literature DB >> 9469461

Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.

I Goya1, J Gutiérrez, R Varona, L Kremer, A Zaballos, G Márquez.   

Abstract

Chemokine receptor-like 1 (CKR-L1) was described recently as a putative seven-transmembrane human receptor with many of the structural features of chemokine receptors. To identify the ligand of CKR-L1, we have studied chemokine-induced calcium mobilization in 293 cells transfected with CKR-L1. Of 20 different chemokines tested, only I-309 was able to elicit a significant calcium mobilization. In addition, I-309 induced the transfectants to migrate in vitro. As expected for chemokine receptor-mediated effects, pertussis toxin, but not cholera toxin, inhibited both the calcium flux and migration of the CKR-L1 transfectants in response to I-309. All of these data support the conclusion that I-309 is a functional ligand for CKR-L1. According to the current chemokine receptor nomenclature, we have designated this gene as CCR8. The murine CCR8 (mCCR8) gene was cloned, and its predicted amino acid sequence showed a 71% identity with that of human CCR8. As human CCR8, mCCR8 is expressed in thymus. Both I-309 and its murine homologue TCA-3 were able to induce calcium mobilization in transiently transfected 293-EBNA cells expressing mCCR8. The affinity of the binding of 125I-labeled TCA-3 to mCCR8 was high (Kd approximately 2 nM); the binding was prevented completely by an excess of cold TCA-3, and only partially competed (40%) by I-309. The identification of I-309 and TCA-3 as the functional ligands for CCR8 receptors will help to unravel the role of these proteins in physiologic and pathologic situations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease.

Authors:  Johannes Grosse; Violeta Chitu; Andreas Marquardt; Petra Hanke; Carolin Schmittwolf; Lutz Zeitlmann; Patricia Schropp; Bettina Barth; Philipp Yu; Rainer Paffenholz; Gabriele Stumm; Michael Nehls; E Richard Stanley
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

2.  Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

Authors:  R M Scoggins; J R Taylor; J Patrie; A B van't Wout; H Schuitemaker; D Camerini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages.

Authors:  Corinna Trebst; Susan M Staugaitis; Pia Kivisäkk; Don Mahad; Martha K Cathcart; Barbara Tucky; Tao Wei; Mysore R Sandhya Rani; Richard Horuk; Kenneth D Aldape; Carlos A Pardo; Claudia F Lucchinetti; Hans Lassmann; Richard M Ransohoff
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

4.  C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity.

Authors:  Catherine Denis; Kathleen Deiteren; Anneleen Mortier; Amel Tounsi; Erik Fransen; Paul Proost; Jean-Christophe Renauld; Anne-Marie Lambeir
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

5.  Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice.

Authors:  S W Chensue; N W Lukacs; T Y Yang; X Shang; K A Frait; S L Kunkel; T Kung; M T Wiekowski; J A Hedrick; D N Cook; A Zingoni; S K Narula; A Zlotnik; F J Barrat; A O'Garra; M Napolitano; S A Lira
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

6.  The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.

Authors:  M J Endres; C G Garlisi; H Xiao; L Shan; J A Hedrick
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

Review 7.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

8.  The human cutaneous chemokine system.

Authors:  Michelle L McCully; Bernhard Moser
Journal:  Front Immunol       Date:  2011-08-09       Impact factor: 7.561

9.  A skin-selective homing mechanism for human immune surveillance T cells.

Authors:  Patrick Schaerli; Lisa Ebert; Katharina Willimann; Andrea Blaser; Regula Stuber Roos; Pius Loetscher; Bernhard Moser
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

10.  Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.

Authors:  Suvendu Das; Eliana Sarrou; Simona Podgrabinska; Melanie Cassella; Sathish Kumar Mungamuri; Nikki Feirt; Ronald Gordon; Chandandeep S Nagi; Yarong Wang; David Entenberg; John Condeelis; Mihaela Skobe
Journal:  J Exp Med       Date:  2013-07-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.